Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program
- PMID: 8314608
Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program
Abstract
This paper uses claims data from the prescription drug program for the elderly in British Columbia to describe temporal trends in prescription drug use and the determinants of those trends. Drug expenditures under the program increased by 317% from $21.6 million in 1981-82 to $90 million in 1988-89. Of the $68.4 million-dollar increase in overall expenditures, 34% was due to new drugs, 24% to increased age-specific utilization rates of old drugs, 21% to increased prices of old drugs, and 14% to the increased size of the elderly population. The analysis indicates that 61.5% of new drug expenditures can be attributed to four specific drugs and that the relative importance of price and utilization rates in determining changes in expenditures on old drugs varies by drug category. The paper provides a framework for understanding and predicting expenditures for drug benefit plans.
Similar articles
-
Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.Health Policy. 2004 Jun;68(3):299-307. doi: 10.1016/j.healthpol.2003.10.006. Health Policy. 2004. PMID: 15113641
-
Prescription drugs: issues of cost, coverage, and quality.EBRI Issue Brief. 1999 Apr;(208):1-21. EBRI Issue Brief. 1999. PMID: 10539445
-
Trends in prescription drug expenditures by Medicaid enrollees.Med Care. 2006 May;44(5 Suppl):I27-35. doi: 10.1097/01.mlr.0000208132.36055.84. Med Care. 2006. PMID: 16625061
-
Economic evaluation of drug prescription monitoring systems in the extra-hospital environment.Ann Ist Super Sanita. 1991;27(2):225-33. Ann Ist Super Sanita. 1991. PMID: 1755575 Review.
-
Persistence in the use of pharmaceuticals by the elderly. Evidence from annual claims.J Health Econ. 1992 Oct;11(3):315-28. doi: 10.1016/0167-6296(92)90006-m. J Health Econ. 1992. PMID: 10122541 Review.
Cited by
-
Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.Br J Clin Pharmacol. 2008 Dec;66(6):885-95. doi: 10.1111/j.1365-2125.2008.03282.x. Br J Clin Pharmacol. 2008. PMID: 19032730 Free PMC article.
-
Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004.Healthc Policy. 2005 Sep;1(1):85-99. Healthc Policy. 2005. PMID: 19308105 Free PMC article.
-
The impact of cost sharing on antidepressant use among older adults in British Columbia.Psychiatr Serv. 2008 Apr;59(4):377-83. doi: 10.1176/ps.2008.59.4.377. Psychiatr Serv. 2008. PMID: 18378836 Free PMC article.
-
Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.CMAJ. 2002 Mar 19;166(6):737-45. CMAJ. 2002. PMID: 11944760 Free PMC article.
-
Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.BMJ. 2004 Mar 6;328(7439):560. doi: 10.1136/bmj.38020.698194.F6. Epub 2004 Feb 24. BMJ. 2004. PMID: 14982865 Free PMC article. Clinical Trial.